These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6360225)

  • 1. The role of placental urokinase inhibitor in toxemia of pregnancy.
    Terao T; Kobayashi T
    Biol Res Pregnancy Perinatol; 1983; 4(4):145-51. PubMed ID: 6360225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of placental plasminogen activator (PPA).
    Kobayashi T; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrinolysis in pregnancy toxemia].
    Kano A
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2311-20. PubMed ID: 6607299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators.
    Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC
    Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
    Christensen U; Holmberg L; Bladh B; Astedt B
    Thromb Haemost; 1982 Aug; 48(1):24-6. PubMed ID: 6813991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y; Hayashi Y; Imai Y; Itoh H
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
    Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic therapy for toxemia of late pregnancy--experimental studies of pregnant rabbits treated with urokinase].
    Kano A
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):72-80. PubMed ID: 6699451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
    Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
    Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD
    Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immobilization of plasminogen activator, urokinase, on nylon.
    Sugitachi A; Takagi K; Imaoka S; Kosaki G
    Thromb Haemost; 1978 Apr; 39(2):426-36. PubMed ID: 580991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium.
    Walker JE; Gow L; Campbell DM; Ogston D
    Thromb Haemost; 1983 Feb; 49(1):21-3. PubMed ID: 6221434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of Immunoassay of Urinary urokinase inhibitor using biological binding activity of urokinase and urokinase inhibitor (author's transl)].
    Yoshio T; Kan S; Ninagawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr; 34(4):451-9. PubMed ID: 7040569
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental and clinical studies on coagulation and fibrinolysis in toxemia of pregnancy].
    Motohara N
    Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):215-26. PubMed ID: 6620689
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation of peptides with anti-urokinase activity from the human placenta.
    Uszynski M
    Thromb Haemost; 1980 Feb; 42(5):1411-6. PubMed ID: 6768150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.
    Estellés A; Gilabert J; España F; Aznar J; Galbis M
    Am J Obstet Gynecol; 1991 Jul; 165(1):138-42. PubMed ID: 1906680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation, fibrinolysis, platelet and kinin-forming systems during toxemia of pregnancy.
    Maki M
    Biol Res Pregnancy Perinatol; 1983; 4(4):152-4. PubMed ID: 6652168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New theory of fibrinolytic mechanism in the development of hyaline membrane disease in newborn infants].
    Uszyńska-Folejewska R; Uszyński M
    Pediatr Pol; 1975 Dec; 50(12):1513-5. PubMed ID: 127976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.